Skip to content

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03559179
Acronym
COMPUTE
Enrollment
55
Registered
2018-06-18
Start date
2018-04-30
Completion date
2019-02-14
Last updated
2020-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-use Disorder

Keywords

CDS, Medication Assisted Therapy

Brief summary

The primary objective of this pilot study is to program an opioid use disorder (OUD) clinical decision support (CDS) tool for use in an electronic medical record (EMR) and obtain high primary care physician (PCP) usability and acceptability. The OUD-CDS is based on the NIDA-Blending Initiative white paper, Clinical Decision Support for Opioid Use Disorders: Working Group Report, which itself is based on national evidence-based guidelines (American Society of Addiction Medicine (ASAM 2015), VA (VA 2015). As such, this pilot study aims to help PCPs achieve accepted standards of care in OUD treatment. The secondary objectives of this pilot study are to evaluate the usefulness of the tool by comparing OUD case-finding, medication-assisted therapy (MAT) and referral patterns pre- and post-CDS deployment for PCPs with and without CDS access.

Interventions

The Opioid Wizard is an OUD clinical decision support tool for primary care providers.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Hennepin Healthcare Research Institute
CollaboratorOTHER
HealthPartners Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Be an MD, Doctor of Osteopathy, Nurse Practitioner or Physician's Assistant engaged in independent primary care of adults at HealthPartners or Park Nicollet * Have at least schedule 3 DEA prescribing privileges * Voluntarily provide written informed consent to participate in this study

Exclusion criteria

* Less than half-time clinical primary care responsibilities

Design outcomes

Primary

MeasureTime frameDescription
Intervention PCP Confidence in Assessing and Treating OUDThis outcome measure was calculated at approximately month 10 of the pilot study\# of intervention PCPs who report feeling moderately or very confident in assessing and treating OUD.
Intervention PCP Likeliness to Recommend Use of the OUD-CDSThis was calculated after PCP surveys were completed, approximately month 10\# of PCPs with CDS access who rate the OUD-CDS \>4 on a 5-point Likert scale of likeliness to recommend use of the tool to their colleagues. The scale ranges from 1-not at all likely to 5-very likely, with higher values representing a higher likelihood of recommending the OUD-CDS to other colleagues.

Secondary

MeasureTime frameDescription
Compare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.This was calculated at the end of the pilot study (month 8).Calculate and compare the number of patients diagnosed with OUD pre- and post-intervention. This will be presented as rate of OUD diagnoses per patient year.
Compare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.This was calculated at the end of the pilot study (month 8).Calculate and compare the rate of MAT use among patients with OUD pre- and post-intervention. This is presented as a pre/post ratio of MAT rx per patient year.
Compare Post-intervention Referral Patterns Between Intervention and Control GroupsThis was calculated at the end of the pilot study (month 8).Calculate and compare how often patients diagnosed with OUD are referred to specialty care or inpatient treatment post-intervention. Compare these rates between intervention and control groups.

Countries

United States

Participant flow

Participants by arm

ArmCount
Waivered Providers Received the Opioid Wizard
These providers received the OUD clinical decision support tool (Opioid Wizard). Opioid Wizard: The Opioid Wizard is an OUD clinical decision support tool for primary care providers.
8
Non-Waivered Providers Who Received the Opioid Wizard
Non-Buprenorphine waivered providers were randomized to receive/not receive the Opioid Wizard. This arm represents non-waivered providers who received the OUD clinical decision support tool (Opioid Wizard). Opioid Wizard: The Opioid Wizard is an OUD clinical decision support tool for primary care providers.
24
Non-Waivered Providers Who do Not Receive the Opioid Wizard
These are non-buprenorphine waivered providers continued to treat their patients as usual.
23
Total55

Baseline characteristics

CharacteristicWaivered Providers Received the Opioid WizardNon-Waivered Providers Who Received the Opioid WizardNon-Waivered Providers Who do Not Receive the Opioid WizardTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
8 Participants23 Participants23 Participants54 Participants
Race/Ethnicity, Customized
Asian
0 Participants4 Participants2 Participants6 Participants
Race/Ethnicity, Customized
Black
1 Participants1 Participants1 Participants3 Participants
Race/Ethnicity, Customized
Multiple
1 Participants0 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Unknown
1 Participants0 Participants1 Participants2 Participants
Race/Ethnicity, Customized
White
5 Participants19 Participants18 Participants42 Participants
Sex: Female, Male
Female
4 Participants13 Participants16 Participants33 Participants
Sex: Female, Male
Male
4 Participants11 Participants7 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 240 / 23
other
Total, other adverse events
0 / 80 / 240 / 23
serious
Total, serious adverse events
0 / 80 / 240 / 23

Outcome results

Primary

Intervention PCP Confidence in Assessing and Treating OUD

\# of intervention PCPs who report feeling moderately or very confident in assessing and treating OUD.

Time frame: This outcome measure was calculated at approximately month 10 of the pilot study

Population: This outcome was to help show proof of the OUD-CDS concept using responses from intervention PCPs. One intervention provider stopped working for the organization during the intervention. Two additional intervention providers in the Non-Waivered providers who received the Opioid Wizard arm did not complete follow-up surveys.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Waivered Providers Received the Opioid WizardIntervention PCP Confidence in Assessing and Treating OUD# of INT PCPs reporting confidence assessing OUD6 Participants
Waivered Providers Received the Opioid WizardIntervention PCP Confidence in Assessing and Treating OUD# of INT PCPs reporting confidence treating OUD8 Participants
Non-Waivered Providers Who Received the Opioid WizardIntervention PCP Confidence in Assessing and Treating OUD# of INT PCPs reporting confidence treating OUD1 Participants
Non-Waivered Providers Who Received the Opioid WizardIntervention PCP Confidence in Assessing and Treating OUD# of INT PCPs reporting confidence assessing OUD11 Participants
Primary

Intervention PCP Likeliness to Recommend Use of the OUD-CDS

\# of PCPs with CDS access who rate the OUD-CDS \>4 on a 5-point Likert scale of likeliness to recommend use of the tool to their colleagues. The scale ranges from 1-not at all likely to 5-very likely, with higher values representing a higher likelihood of recommending the OUD-CDS to other colleagues.

Time frame: This was calculated after PCP surveys were completed, approximately month 10

Population: One non-waivered intervention provider stopped working for the organization and two additional non-waivered intervention providers did not complete the follow-up survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Waivered Providers Received the Opioid WizardIntervention PCP Likeliness to Recommend Use of the OUD-CDS6 Participants
Non-Waivered Providers Who Received the Opioid WizardIntervention PCP Likeliness to Recommend Use of the OUD-CDS13 Participants
Secondary

Compare Post-intervention Referral Patterns Between Intervention and Control Groups

Calculate and compare how often patients diagnosed with OUD are referred to specialty care or inpatient treatment post-intervention. Compare these rates between intervention and control groups.

Time frame: This was calculated at the end of the pilot study (month 8).

ArmMeasureValue (NUMBER)
Waivered Providers Received the Opioid WizardCompare Post-intervention Referral Patterns Between Intervention and Control Groups0.99 post/pre ratio of referral per pt. year
Non-Waivered Providers Who Received the Opioid WizardCompare Post-intervention Referral Patterns Between Intervention and Control Groups1.21 post/pre ratio of referral per pt. year
Did Not Receive the Opioid WizardCompare Post-intervention Referral Patterns Between Intervention and Control Groups1.04 post/pre ratio of referral per pt. year
Secondary

Compare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.

Calculate and compare the rate of MAT use among patients with OUD pre- and post-intervention. This is presented as a pre/post ratio of MAT rx per patient year.

Time frame: This was calculated at the end of the pilot study (month 8).

ArmMeasureValue (NUMBER)
Waivered Providers Received the Opioid WizardCompare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.1.4 pre/post ratio MAT Rx per patient year
Non-Waivered Providers Who Received the Opioid WizardCompare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.1.1 pre/post ratio MAT Rx per patient year
Did Not Receive the Opioid WizardCompare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.1.03 pre/post ratio MAT Rx per patient year
Secondary

Compare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.

Calculate and compare the number of patients diagnosed with OUD pre- and post-intervention. This will be presented as rate of OUD diagnoses per patient year.

Time frame: This was calculated at the end of the pilot study (month 8).

ArmMeasureValue (NUMBER)
Waivered Providers Received the Opioid WizardCompare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.11.3 OUD diagnosis per patient year
Non-Waivered Providers Who Received the Opioid WizardCompare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.28.54 OUD diagnosis per patient year
Did Not Receive the Opioid WizardCompare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.7.87 OUD diagnosis per patient year

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026